- Home
- Publications
- Publication Search
- Publication Details
Title
Triple negative breast cancer in the era of miRNA
Authors
Keywords
Triple negative breast cancer, MicroRNAs, Epigenomics, Neoplasm, Metastasis
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 157, Issue -, Pages 103196
Publisher
Elsevier BV
Online
2020-12-09
DOI
10.1016/j.critrevonc.2020.103196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
- (2020) Paula I Gonzalez‐Ericsson et al. JOURNAL OF PATHOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
- (2019) Laura Cantini et al. NUCLEIC ACIDS RESEARCH
- Systematic Review of miR-29 in Cancer
- (2019) Jason J. Kwon et al. Molecular Therapy-Oncolytics
- The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma
- (2019) Xue Bai et al. PLoS One
- Nanoparticle Delivery of miR-708 Mimetic Impairs Breast Cancer Metastasis
- (2019) Divya Ramchandani et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer
- (2019) PV Raninga et al. INTERNATIONAL JOURNAL OF CANCER
- Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
- (2019) Gloria V. Echeverria et al. Science Translational Medicine
- MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
- (2019) Qian Tang et al. Artificial Cells Nanomedicine and Biotechnology
- Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Tomas G. Lyons CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer
- (2018) Javad Razaviyan et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1
- (2018) Jianli Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNAs as novel biomarkers for colorectal cancer: New outlooks
- (2018) Naghmeh Shirafkan et al. BIOMEDICINE & PHARMACOTHERAPY
- Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007
- (2018) Naoise C. Synnott et al. CANCER LETTERS
- Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway
- (2018) Yajuan Xiao et al. CANCER LETTERS
- Emerging therapeutic modalities of PARP inhibitors in breast cancer
- (2018) Xin Wang et al. CANCER TREATMENT REVIEWS
- Breast Cancer and Ovulation Induction Treatments
- (2018) Robabeh Taheripanah et al. Clinical Breast Cancer
- Novel prognostic and predictive microRNA targets for triple-negative breast cancer
- (2018) Gulisa Turashvili et al. FASEB JOURNAL
- Neuroprotection afforded by circadian regulation of intracellular glutathione levels: A key role for miRNAs
- (2018) Chisato Kinoshita et al. FREE RADICAL BIOLOGY AND MEDICINE
- Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
- (2018) Janaki Ramaiah Mekala et al. GENE
- MicroRNAs in regulation of triple-negative breast cancer progression
- (2018) Dominika Piasecka et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Role of miR-203 in estrogen receptor-mediated signaling in the rat uterus and endometrial carcinoma
- (2018) Oliver Zierau et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Circular RNA and its mechanisms in disease: From the bench to the clinic
- (2018) Bing Han et al. PHARMACOLOGY & THERAPEUTICS
- Angiogenic role of miR-20a in breast cancer
- (2018) Gines Luengo-Gil et al. PLoS One
- MicroRNA-10b expression in breast cancer and its clinical association
- (2018) Jianhui Zhang et al. PLoS One
- MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
- (2018) Yaming Li et al. Cell Death & Disease
- The versatile nature of miR-9/9* in human cance
- (2018) Katarzyna Nowek et al. Oncotarget
- The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b
- (2018) Khalid Sossey-Alaoui et al. Scientific Reports
- Increased expression of miR-155 and miR-222 is associated with lymph node positive status
- (2018) Vladimir Chernyy et al. Journal of Cancer
- Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection
- (2018) Vrantika Chaudhary et al. JOURNAL OF NANOBIOTECHNOLOGY
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- Notch, BMP and WNT/β-catenin network is impaired in endothelial cells of the patients with thoracic aortic aneurysm
- (2018) Aleksandra Kostina et al. ATHEROSCLEROSIS SUPPLEMENTS
- Epigenetics and Epi-miRNAs: Potential markers/therapeutics in leukemia
- (2018) Fatemeh Memari et al. BIOMEDICINE & PHARMACOTHERAPY
- Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
- (2018) Patricia Midori Murobushi Ozawa et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic Markers in Triple-Negative Breast Cancer
- (2018) Zuzana Sporikova et al. Clinical Breast Cancer
- Reversal of Triple-negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immune-Suppression
- (2018) Thomas J. Rogers et al. MOLECULAR CANCER RESEARCH
- Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
- (2018) Thomas Treiber et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
- (2018) Mihriban Karaayvaz et al. Nature Communications
- MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
- (2018) Mustafa Kahraman et al. Scientific Reports
- Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
- (2018) Simona D’Aguanno et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
- (2018) Gaofeng Xiong et al. Nature Communications
- HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation
- (2018) Zuo-Lin Li et al. KIDNEY INTERNATIONAL
- Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer
- (2017) Min Hye Jang et al. HUMAN PATHOLOGY
- The role of exosomes and miRNAs in drug-resistance of cancer cells
- (2017) Duc-Hiep Bach et al. INTERNATIONAL JOURNAL OF CANCER
- Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity
- (2017) Junling Liu et al. JOURNAL OF PATHOLOGY
- miR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha
- (2017) Li-Li Liu et al. MOLECULAR MEDICINE
- Integrated analysis of the potential roles of miRNA-mRNA networks in triple negative breast cancer
- (2017) Huiru Zhu et al. Molecular Medicine Reports
- miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions
- (2017) Chih-Hung Chou et al. NUCLEIC ACIDS RESEARCH
- LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism
- (2017) Gangqiang Ding et al. OncoTargets and Therapy
- miR-200b inhibits CD133+ glioma cells by targeting the AKT pathway
- (2017) Aiqun Liu et al. Oncology Letters
- Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation
- (2017) Rosa Drago-Ferrante et al. Oncotarget
- miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans
- (2017) Q Zheng et al. Oncogenesis
- Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment
- (2017) Emma Bell et al. Computational and Structural Biotechnology Journal
- Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis
- (2017) Jacek M. Kwiecien et al. PLoS One
- Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer
- (2016) Zhongxing Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer
- (2016) Jiawei Chen et al. BMC CANCER
- Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer
- (2016) Yongwen Li et al. CANCER BIOLOGY & THERAPY
- MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer
- (2016) L Tang et al. CANCER GENE THERAPY
- New Insights Into miR-17–92 Cluster Regulation and Angiogenesis
- (2016) Jan Fiedler et al. CIRCULATION RESEARCH
- MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer
- (2016) Long-ji Luo et al. GENE
- Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1
- (2016) Valentina Damiano et al. GENES CHROMOSOMES & CANCER
- MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
- (2016) Caterina Catalanotto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1
- (2016) Sukanya Shyamasundar et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer
- (2016) Lei Huo et al. MODERN PATHOLOGY
- The tumour hypoxia induced non-coding transcriptome
- (2016) Hani Choudhry et al. MOLECULAR ASPECTS OF MEDICINE
- Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
- (2016) S Baroni et al. Cell Death & Disease
- A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
- (2016) Le Qu et al. Nature Communications
- Inhibition of miR-21 by 3′/5′-Serinyl-Capped 2′-O-Methyl RNA Interspersed with 2′-O-(2-Amino-3-Methoxypropyl) Uridine Units
- (2016) Smita Nahar et al. Nucleic Acid Therapeutics
- RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis
- (2016) Feifei Chen et al. Oncotarget
- High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
- (2016) Zhi-Gang Cao et al. Oncotarget
- miR-182 Regulates Metabolic Homeostasis by Modulating Glucose Utilization in Muscle
- (2016) Duo Zhang et al. Cell Reports
- Effects of mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)/Vascular Endothelial Growth Factor (VEGF) Signal Pathway
- (2016) Feng Yang et al. MEDICAL SCIENCE MONITOR
- microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection
- (2016) Rimi Hamam et al. Scientific Reports
- Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes
- (2015) Yan Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Role of epithelial–mesenchymal transition markers in triple-negative breast cancer
- (2015) Sai Yin Cheung et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer
- (2015) Peng Liu et al. CANCER LETTERS
- miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
- (2015) B. D. Adams et al. CANCER RESEARCH
- miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of theEPHA2oncogene
- (2015) Efrosini Tsouko et al. CARCINOGENESIS
- Expression of epithelial-mesenchymal transition–related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
- (2015) Min Hye Jang et al. HUMAN PATHOLOGY
- miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
- (2015) Andrea Mathe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diverse functions of miR-373 in cancer
- (2015) Furong Wei et al. Journal of Translational Medicine
- Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
- (2015) Y. Zhao et al. ONCOLOGIST
- Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development
- (2015) Chuan Jin et al. TUMOR BIOLOGY
- MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer
- (2015) De Chen et al. Oncotarget
- MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
- (2015) Leticia De Mattos-Arruda et al. Oncotarget
- MicroRNA-21 Regulates PI3K/Akt/mTOR Signaling by Targeting TGFβI during Skeletal Muscle Development in Pigs
- (2015) Lijing Bai et al. PLoS One
- IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer
- (2015) Biao Dong et al. PLoS One
- MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
- (2015) Ye Song et al. Oncotarget
- Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
- (2014) T. Umezu et al. BLOOD
- The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster
- (2014) Lianjin Jin et al. BREAST CANCER RESEARCH AND TREATMENT
- Critical role of miR-10b in transforming growth factor-β1-induced epithelial–mesenchymal transition in breast cancer
- (2014) Xu Han et al. CANCER GENE THERAPY
- MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
- (2014) Brock Humphries et al. CARCINOGENESIS
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- MicroRNA control of epithelial-mesenchymal transition in cancer stem cells
- (2014) Jin Hao et al. INTERNATIONAL JOURNAL OF CANCER
- Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
- (2014) S. Ramakrishnan et al. Journal of Neuroimmune Pharmacology
- MicroRNA-542-3p inhibits tumour angiogenesis by targeting Angiopoietin-2
- (2014) Ting He et al. JOURNAL OF PATHOLOGY
- lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
- (2014) Gabriel Eades et al. MOLECULAR CANCER RESEARCH
- microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells
- (2014) YI REN et al. Molecular Medicine Reports
- miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer
- (2014) Jun Wang et al. Molecular Oncology
- MiR-148a- and miR-216a-regulated Oncolytic Adenoviruses Targeting Pancreatic Tumors Attenuate Tissue Damage Without Perturbation of miRNA Activity
- (2014) Xavier Bofill-De Ros et al. MOLECULAR THERAPY
- A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
- (2014) Songjie Shen et al. PLoS One
- MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
- (2014) Imen Medimegh et al. PLoS One
- miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
- (2014) C Denoyelle et al. Cell Death & Disease
- Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis
- (2014) D Zhang et al. Cell Death & Disease
- MiR-9 promotes microglial activation by targeting MCPIP1
- (2014) Honghong Yao et al. Nature Communications
- Hypoxia-regulated microRNAs in human cancer
- (2013) Guomin Shen et al. ACTA PHARMACOLOGICA SINICA
- Connect the dots
- (2013) Yifei Li et al. Autophagy
- Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
- (2013) Andrea BISSO et al. CELL CYCLE
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
- (2013) E Mogilyansky et al. CELL DEATH AND DIFFERENTIATION
- Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
- (2013) C. Eichelser et al. CLINICAL CHEMISTRY
- Regulation of Breast Cancer and Bone Metastasis by MicroRNAs
- (2013) S. Vimalraj et al. DISEASE MARKERS
- MicroRNAs and Triple Negative Breast Cancer
- (2013) Elvira D'Ippolito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment
- (2013) ROBERTA PIVA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice
- (2013) Hiroto Hatakeyama et al. JOURNAL OF CONTROLLED RELEASE
- Genomic and Epigenomic Cross-talks in the Regulatory Landscape of miRNAs in Breast Cancer
- (2013) Devyani Samantarrai et al. MOLECULAR CANCER RESEARCH
- MiR-155 at the heart of oncogenic pathways
- (2013) M F Czyzyk-Krzeska et al. ONCOGENE
- MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer
- (2013) J Johansson et al. ONCOGENE
- Targeted Ablation of miR-21 Decreases Murine Eosinophil Progenitor Cell Growth
- (2013) Thomas X. Lu et al. PLoS One
- miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
- (2013) Rounak Nassirpour et al. PLoS One
- miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
- (2013) Kinya Okamoto et al. PLoS One
- Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis
- (2013) S. T. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-139-5p is a regulator of metastatic pathways in breast cancer
- (2013) K. Krishnan et al. RNA
- Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1
- (2013) Hailing Liu et al. TUMOR BIOLOGY
- Epigenetic Regulation of Cancer Stem Cell Genes in Triple-Negative Breast Cancer
- (2012) Naofumi Kagara et al. AMERICAN JOURNAL OF PATHOLOGY
- TGF-β upregulates miR-181a expression to promote breast cancer metastasis
- (2012) Molly A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
- (2012) Chen Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer
- (2012) Katarzyna Augoff et al. Molecular Cancer
- Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells
- (2012) A. Ahmad et al. MOLECULAR CANCER THERAPEUTICS
- Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
- (2012) Claudia Piovan et al. Molecular Oncology
- Comparing the MicroRNA Spectrum between Serum and Plasma
- (2012) Kai Wang et al. PLoS One
- miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer
- (2012) Erin N. Howe et al. PLoS One
- MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression
- (2011) Bing Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer
- (2011) H Zhang et al. CELL DEATH AND DIFFERENTIATION
- MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer
- (2011) Cathy A. Andorfer et al. TRENDS IN MOLECULAR MEDICINE
- Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
- (2010) Ana Bosch et al. CANCER TREATMENT REVIEWS
- MicroRNA: Biogenesis, Function and Role in Cancer
- (2010) Leigh-Ann MacFarlane et al. CURRENT GENOMICS
- MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features
- (2010) Juan Xu et al. NUCLEIC ACIDS RESEARCH
- Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma
- (2009) Liqiang Qi et al. BMC CANCER
- Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
- (2009) D. R. Hurst et al. CANCER RESEARCH
- Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis
- (2009) Y. Huang et al. CANCER RESEARCH
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More